DEPAKENE

This brand name is authorized in Brazil, Canada, Japan, Mexico.

Active ingredients

The drug DEPAKENE contains one active pharmaceutical ingredient (API):

1	Valproic acid UNII 5VOM6GYJ0D - VALPROATE SODIUM
	Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.
	Read more about Valproic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DEPAKENE Oral solution	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AG01	Valproic acid	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500202401113318, 500202402111319, 500202403132311, 500202404112312, 500202405119310
CA	Health Products and Food Branch	00443832
JP	医薬品医療機器総合機構	1139004C1057, 1139004C2061, 1139004F1096, 1139004F2173, 1139004G1040, 1139004G2063, 1139004Q1100
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	0542M79, 0543M79, 514M99